Repligen Corp. (RGEN)
175.20
-5.78
(-3.19%)
USD |
NASDAQ |
Sep 01, 10:24
Repligen Net Income (TTM) : 41.54M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.54M |
| March 31, 2026 | 51.40M |
| December 31, 2025 | 48.89M |
| September 30, 2025 | 1.738M |
| June 30, 2025 | -13.83M |
| March 31, 2025 | -22.98M |
| December 31, 2024 | -25.51M |
| September 30, 2024 | -8.095M |
| June 30, 2024 | 9.482M |
| March 31, 2024 | 23.56M |
| December 31, 2023 | 35.60M |
| September 30, 2023 | 100.78M |
| June 30, 2023 | 124.26M |
| March 31, 2023 | 154.33M |
| December 31, 2022 | 185.96M |
| September 30, 2022 | 166.34M |
| June 30, 2022 | 159.43M |
| March 31, 2022 | 145.80M |
| December 31, 2021 | 128.29M |
| September 30, 2021 | 118.88M |
| June 30, 2021 | 99.93M |
| March 31, 2021 | 79.56M |
| December 31, 2020 | 59.93M |
| September 30, 2020 | 43.83M |
| June 30, 2020 | 30.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 23.17M |
| December 31, 2019 | 21.41M |
| September 30, 2019 | 23.44M |
| June 30, 2019 | 26.58M |
| March 31, 2019 | 21.22M |
| December 31, 2018 | 16.62M |
| September 30, 2018 | 23.16M |
| June 30, 2018 | 23.03M |
| March 31, 2018 | 28.73M |
| December 31, 2017 | 28.35M |
| September 30, 2017 | 21.20M |
| June 30, 2017 | 17.69M |
| March 31, 2017 | 13.12M |
| December 31, 2016 | 11.68M |
| September 30, 2016 | 6.917M |
| June 30, 2016 | 8.30M |
| March 31, 2016 | 8.041M |
| December 31, 2015 | 9.345M |
| September 30, 2015 | 8.682M |
| June 30, 2015 | 7.610M |
| March 31, 2015 | 6.823M |
| December 31, 2014 | 8.171M |
| September 30, 2014 | 11.90M |
| June 30, 2014 | 16.32M |
| March 31, 2014 | 18.03M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| BioLife Solutions, Inc. | 50.45M |
| Danaher Corp. | 3.99B |
| Liquidia Corp. | 138.61M |
| Harmony Biosciences Holdings, Inc. | 181.27M |
| Agilent Technologies, Inc. | 1.44B |